» Articles » PMID: 29961914

Comparative Study of MicroRNA Profiling in One Chinese Family with PSEN1 G378E Mutation

Overview
Journal Metab Brain Dis
Publisher Springer
Specialties Endocrinology
Neurology
Date 2018 Jul 3
PMID 29961914
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are not widely studied in familial Alzheimer's disease cases, whether the microRNA profilings in familial Alzheimer's disease patients are similar to the sporadic AD patients is not known. This study aims to investigate the differential expression of microRNAs (miRNAs) associated with early-onset familial Alzheimer's disease (EO-FAD) in a Chinese family. We performed the gene mutation analysis in a family clinically diagnosed of EO-FAD. Micro-arrays were used to profile the miRNAs in cerebrospinal fluid of 2 affected members, 2 unaffected carriers and 2 mutation negative controls. The clinical presentation confirmed the EO-FAD diagnosis, and a recurrent mutation of the PSEN1 p.G378E was found in the family. The result showed that in the miRNAs expression profile, a total of 166 miRNAs were up-regulated and 3 miRNAs were down-regulated in the affected individuals compared with mutation negative individuals. But after Benjamini Hochberg FDR correction, only 25 miRNAs were significantly up-regulated and no miRNA was down-regulated, the levels of miR-30a-5p, miR-4758-3p and let-7a-3p were elevated significantly. Compared with mutation negative controls, 21 miRNAs were up-regulated and 18 microRNAs were down-regulated in the unaffected mutation carriers, after Benjamini Hochberg FDR correction, miR-345-5p was up-regulated and miR-4795-3p was down-regulated in the unaffected mutation carriers. And there was no difference between the affected members and unaffected mutation carriers. GO database showed that the top biological processes affected by the predicted target genes are nucleic acid binding transcription factor activity and transcription factor activity (sequence-specific DNA binding) (GO:0001071 and GO:0003700). The result of KEGG pathways showed 64 pathways were implicated in the regulatory network. The present study identified the miRNA profiling of Chinese siblings with G378E mutation in the PSEN1. Compared with mutation negative controls, the levels of 25 miRNAs including miR-30a-5p, miR-4758-3p and let-7a-3p were elevated significantly in the affected members, miR-345-5p was up-regulated and miR-4795-3p was down-regulated in the unaffected mutation carriers. Our study showed the microRNA profilings in the cases of a EO-FAD family with PSEN1 p.G378E mutation, but because of the individuals in the family was small, the results in other types of EO-FAD still need further studied.

Citing Articles

Mesenchymal Stem Cells from Familial Alzheimer's Patients Express MicroRNA Differently.

Rochin-Hernandez L, Rochin-Hernandez L, Padilla-Cristerna M, Duarte-Garcia A, Jimenez-Acosta M, Figueroa-Corona M Int J Mol Sci. 2024; 25(3).

PMID: 38338859 PMC: 10855944. DOI: 10.3390/ijms25031580.


Decreased miR-451a in cerebrospinal fluid, a marker for both cognitive impairment and depressive symptoms in Alzheimer's disease.

Feng H, Hu P, Chen Y, Sun H, Cai J, He X Theranostics. 2023; 13(9):3021-3040.

PMID: 37284450 PMC: 10240826. DOI: 10.7150/thno.81826.


Emerging Role of MicroRNA-30c in Neurological Disorders.

Kumar M, Li G Int J Mol Sci. 2023; 24(1).

PMID: 36613480 PMC: 9819962. DOI: 10.3390/ijms24010037.


A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer's Disease and Mild Cognitive Impairment from Healthy Controls.

Piscopo P, Manzini V, Rivabene R, Crestini A, Le Pera L, Pizzi E Int J Mol Sci. 2022; 23(21).

PMID: 36362022 PMC: 9658433. DOI: 10.3390/ijms232113232.


Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis.

Noronha O, Mesarosovo L, Anink J, Iyer A, Aronica E, Mills J Genes (Basel). 2022; 13(6).

PMID: 35741796 PMC: 9222420. DOI: 10.3390/genes13061034.


References
1.
Li Y, Zhang T, Zhou Y, Sun Y, Cao Y, Chang X . A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis. Sci Rep. 2016; 6:36136. PMC: 5095347. DOI: 10.1038/srep36136. View

2.
Tan L, Yu J, Tan M, Liu Q, Wang H, Zhang W . Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis. 2014; 40(4):1017-27. DOI: 10.3233/JAD-132144. View

3.
Wei W, Yang Y, Cai J, Cui K, Li R, Wang H . MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3. Cell Physiol Biochem. 2016; 39(3):1165-76. DOI: 10.1159/000447823. View

4.
Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T . Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One. 2014; 9(5):e94839. PMC: 4010405. DOI: 10.1371/journal.pone.0094839. View

5.
Bekris L, Leverenz J . The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Neurodegener Dis Manag. 2015; 5(1):61-74. DOI: 10.2217/nmt.14.52. View